Kintz Samuel
Enliven Therapeutics, Inc. · PRESIDENT AND CEO
Kintz Samuel is listed in filings as PRESIDENT AND CEO at Enliven Therapeutics, Inc.. This profile follows SEC Form 4 activity through Nov 19, 2025, including sale activity. Recent filings connect the profile to Enliven Therapeutics, Inc. (ELVN). The current snapshot covers public activity from Jun 27, 2024 to Nov 19, 2025. Reported amounts are shown as $272.7K to $74.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $273k12.5k shares | SellNov 17, 2025 | $21.82 | $53.20 |